Target intelligence / Profile preview

Neuroblastoma breakpoint family, member 6 pseudogene (NBPF6 pseudogene)

Target
NBPF6 pseudogene
Molecular classification
Other (Pseudogene)
01

Overview

Neuroblastoma breakpoint family, member 6 pseudogene (NBPF6 pseudogene, ENSG00000277655), is a non-protein-coding genomic element in humans. It is classified as a pseudogene, meaning it is homologous to the functional NBPF6 gene but contains disablements (such as frameshifts or premature stop codons) that prevent the production of a functional protein product[1][2][6][7]. The NBPF gene family has expanded significantly in the human genome and is notable for high sequence similarity among its members, including both genes and pseudogenes. While some pseudogenes may be transcribed or have regulatory roles, there is no evidence that this specific pseudogene encodes any functional RNA or protein, nor is it implicated directly as a drug target or biomarker. The accurate identification of pseudogenes is important to prevent misannotation and PCR amplification errors in genetic studies[6]. Pseudogenes like this one are generally not considered therapeutic targets, and their functions—when present—are mainly regulatory or evolutionary[2][6][8].

Other names
AC245407.1NBPF6 pseudogene
02

Biological functions

Other (does not encode a functional protein; some pseudogenes can have regulatory RNA function, but none is described for this locus)
03

Disease associations

Other (No direct disease association; the NBPF gene family is implicated in neurogenetic diseases and cancer via functional members, but pseudogene roles are mostly regulatory and rarely direct)

Beyond the preview

Go deeper on Neuroblastoma breakpoint family, member 6 pseudogene (NBPF6 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma breakpoint family, member 6 pseudogene (NBPF6 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call